EcoDrugPlus

Ensembl ID : ENSPNYG00000014258
Gene Symbol: -
Cross references: -
153 Possible Orthologues:

Ensembl ID : ENSPNYG00000000785
Gene Symbol: -
Cross references: -
226 Possible Orthologues:

Ensembl ID : ENSPNYG00000000687
Gene Symbol: -
Cross references: -
211 Possible Orthologues:

Ensembl ID : ENSPNYG00000006348
Gene Symbol: -
Cross references: -
295 Possible Orthologues:

Ensembl ID : ENSPNYG00000020687
Gene Symbol: -
Cross references: -
138 Possible Orthologues:

Ensembl ID : ENSPNYG00000011621
Gene Symbol: -
Cross references: -
179 Possible Orthologues:

Ensembl ID : ENSPNYG00000004991
Gene Symbol: -
Cross references: -
584 Possible Orthologues:

Ensembl ID : ENSPNYG00000017249
Gene Symbol: -
Cross references: -
79 Possible Orthologues:

Ensembl ID : ENSPNYG00000014181
Gene Symbol: -
Cross references: -
157 Possible Orthologues:

Ensembl ID : ENSPNYG00000022245
Gene Symbol: -
Cross references: -
208 Possible Orthologues:

Ensembl ID : ENSPNYG00000024220
Gene Symbol: -
Cross references: -
229 Possible Orthologues:

Ensembl ID : ENSPNYG00000019350
Gene Symbol: -
Cross references: -
13 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).